← Back to Clinical Trials
Recruiting NCT05339477

NCT05339477 The Physical Activity Post Myocardial Infarction SWEDEHEART Prospective Cohort Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05339477
Status Recruiting
Phase
Sponsor Sahlgrenska University Hospital
Condition Myocardial Infarction
Study Type OBSERVATIONAL
Enrollment 4,000 participants
Start Date 2022-04-26
Primary Completion 2026-04-26

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 79 Years
Study Type OBSERVATIONAL
Interventions
Accelerometer measurement

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 4,000 participants in total. It began in 2022-04-26 with a primary completion date of 2026-04-26.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The association between objectively measured physical activity intensities (light, moderate and vigorous), sedentary time and clinical outcomes has not been clarified in patients after a myocardial infarction. The overall objective of the study is to explore associations between accelerometer measured physical activity and clinical outcomes after a myocardial infarction. Moreover, the association between changes in physical activity and outcomes will be assessed.

Eligibility Criteria

Inclusion Criteria: * Signed informed consent * Diagnosis of a type 1 myocardial infarction registered in SWEDEHEART * Age 18-79 years at discharge from hospital * Attending the first visit in the cardiac rehabilitation (CR) registry SEPHIA (2 months after discharge) Exclusion Criteria: * Inability to understand Swedish * Non-ambulatory * Any mental condition that may interfere with the possibility for the patient to comply with the study protocol

Contact & Investigator

Central Contact

Maria Bäck, PhD

✉ maria.m.back@vgregion.se

📞 +46313421195

Principal Investigator

Maria Bäck, PhD

PRINCIPAL INVESTIGATOR

Department of physiotherapy, Sahlgrenska University Hospital

Frequently Asked Questions

Who can join the NCT05339477 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 79 Years, studying Myocardial Infarction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05339477 currently recruiting?

Yes, NCT05339477 is actively recruiting participants. Contact the research team at maria.m.back@vgregion.se for enrollment information.

Where is the NCT05339477 trial being conducted?

This trial is being conducted at Alingsås, Sweden, Bäckefors, Sweden, Bollnäs, Sweden, Eksjö, Sweden and 11 additional locations.

Who is sponsoring the NCT05339477 clinical trial?

NCT05339477 is sponsored by Sahlgrenska University Hospital. The principal investigator is Maria Bäck, PhD at Department of physiotherapy, Sahlgrenska University Hospital. The trial plans to enroll 4,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology